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Abstract
Terminal differentiation of skin keratinocytes is a vertically directed multi-step process that is tightly controlled by the
sequential expression of a variety of genes. In this study, we investigated the role of the POU domain-containing
transcription factor Brn2 in keratinocyte differentiation. Immunohistochemical analysis showed that Brn2 is expressed
primarily in the upper granular layer. Consistent with its epidermal localization, Brn2 expression was highly induced at 14
days after calcium treatment of cultured normal human epidermal keratinocytes. When Brn2 was overexpressed by
adenoviral transduction, Brn2 led to increased expression of the differentiation-related genes involucrin, filaggrin, and
loricrin in addition to inhibition of their proliferation. Chromatin immunoprecipitation demonstrated that Brn2 bound to the
promoter regions of these differentiation-related genes. We injected the purified Brn2 adenovirus into rat skin, which led to
a thickened epidermis with increased amounts of differentiation related markers. The histopathologic features of
adenovirus-Brn2 injected skin tissues looked similar to the features of lichen planus, a human skin disease showing chronic
inflammation and well-differentiated epidermal changes. Moreover, Brn2 is shown to be expressed in almost all cell nuclei of
the thickened epidermis of lichen planus, and Brn2 also attracts T lymphocytes. Our results demonstrate that Brn2 is
probably a transcriptional factor playing an important role in keratinocyte differentiation and probably also in the
pathogenesis of lichen planus lesions.
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Introduction
Terminal differentiation of skin keratinocytes, in which the
transition from basal keratinocytes to corneocytes is occurred, is a
complex process that requires the simultaneous activation and
inactivation of a wide variety of genes that must be expressed at
the correct time and in the correct location [1]. Some
characteristic genes expressed at different stages of keratinocyte
maturation, such as involucrin, loricrin and filaggrin, are well
documented [2]. In addition, a number of ubiquitous transcription
factors, such as AP1, Sp1, and the AP2 family members, are
involved in regulating keratinocyte gene expression and differen-
tiation [3]. Although the functional involvement of many
transcription factors in keratinocyte differentiation has been
known, however, it is not sufficient to understand the sophisticated
regulatory mechanism underlying this process. In this study, we
identify a POU domain-containing transcription factor Brn2 as an
important regulator in keratinocyte differentiation.
POU domain proteins have been implicated in development,
replication, growth and cell cycle arrest, and differentiation [4–6].
Especially, POU domain-containing transcription factor Brn2
(also called N-Oct3 and POU3F2) has been implicated in both
neuronal differentiation and activation of the corticotrophin-
releasing hormone gene [7–9]. Targeted disruption of the Brn2
gene in mice results in loss of specific neuronal lineages in the
hypothalamus and consequent loss of the posterior pituitary gland
[9,10]. Brn2 negative mice, therefore, die within 10 days of birth,
although the specific cause of death is not apparent. As for skin
cells, evidence also implicates it in melanoma growth and survival.
Brn2 is overexpressed in human melanoma cell lines compared to
normal melanocytes [11,12], and it appears to play a role in
melanoma cell proliferation and tumorigenesis [13,14]. In
melanoma, Brn2 is a focus for convergence of the MAP kinase
and Wnt/b-catenin signaling pathways that are linked to cell
proliferation [15,16]. However, the expression and putative role of
Brn2 in keratinocytes have not been clearly elucidated yet.
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13216Although the importance of Brn2 in neuronal differentiation
and melanoma development is recognized, however, the expres-
sion and putative role of Brn2 in epidermal keratinocytes have not
been clearly elucidated yet. In this study, we provide evidences
that Brn2 is a transcriptional factor playing an important role in
keratinocyte differentiation, and probably also in the pathogenesis
of lichen planus lesions.
Results
Expression of Brn2 in epidermal keratinocytes
To investigate the Brn2 expression during keratinocyte
differentiation, we adopted a well-established calcium-induced
differentiation model [17]. RT-PCR analysis clearly showed that
the expression of Brn2 was increased at 14 days after calcium
treatment (Figure 1A). Protein analysis using Western blotting also
identified endogenous Brn2 expression in 14 day induced cells
(Figure 1B). Consistent with, immunohistochemistry showed that
Brn2 expression was increased in the granular layer of the
epidermis (Figure 1C).
Brn2 regulates the expression of keratinocyte
differentiation markers
Since the expression of Brn2 was increased in the granular layer
of the epidermis as well as in the differentiated keratinocytes by
calcium, we speculated that Brn2 has a role for keratinocyte
differentiation. To test this idea, we made the recombinant
adenovirus expressing green fluorescent protein-tagged Brn2
(GFP-Brn2), and transduced cultured human epidermal keratino-
cytes. When overexpressed, Brn2 was located in nuclei of
keratinocytes (Figure 2A). We then determined the effect of
Brn2 on the expression of keratinocyte differentiation markers. As
shown in Figure 2B, Brn2 increased expression of keratinocyte
differentiation markers involucrin, loricrin, and filaggrin. The
same results were obtained at protein levels (Figure 2C). To
determine whether Brn2 effect was at the promoter level, we
transduced keratinocytes with involucrin-luc reporter adenovirus-
es, in which about 3.7 kb of involucrin promoter fragment was
fused to luciferase gene. Overexpression of Brn2 significantly
increased the luciferase activities, in both the absence and presence
of calcium (Figure 2D).
To further verify whether Brn2 directly regulates the transcrip-
tion of differentiation-related genes, we searched for Brn2-binding
site(s) using UCSC Genome Bioinformatics Program search
engines and the Computational Biology Research Center pro-
gram (http://genome.ucsc.edu.http://www.cbrc.jp/research/db/
TFSEARCH.html). As a result, we found the putative Brn2-
binding sites from promoters of involucrin, loricrin and filaggrin
genes (Figure 3A). Consecutive chromatin immunoprecipitation
(ChIP) assay clearly revealed that Brn2 bound to the promoters of
involucrin, loricrin and filaggrin genes (Figure 3B). These results
indicate that Brn2 is a functional transcription factor directly
involved in the expression of involucrin, loricrin and filaggrin.
Brn2 reduces the growth of keratinocytes
Keratinocyte proliferation assays were performed to determine
the effects of Brn2 on the keratinocyte growth. Keratinocytes were
plated at a low density and after transduction with Brn2
adenovirus, grown for 3 days. The proliferation rate was
determined using a thymidine assay. When Brn2 was overex-
pressed in keratinocytes, significant retardation of cell growth was
observed (Figure 4A). To investigate how Brn2 affects the cell
cycle, we determined which components of cell cycle-controlling
molecules were affected by Brn2. As shown in Figure 4B, Brn2
increased the expression of the cell cycle regulators such as p53,
p21 and Rb, while it decreased expression of PCNA.
Figure 1. Expression of Brn2 in epidermal keratinocytes. (A) Keratinocytes were treated with 1.2 mM calcium at the indicated time points. The
mRNA level for Brn2 was increased in a time-dependent manner during calcium-induced keratinocyte differentiation. Involucrin was used as a
positive control for induction of keratinocyte differentiation. Cyclophilin was used as a loading control. (B) The protein level for Brn2 was detected by
Western blot analysis. Involucrin and actin were used for positive control and loading control, respectively. (C) Immunohistochemical analysis of the
Brn2 expression. Section of paraffin-embedded skin tissue was stained with anti-Brn2 antibody. Brn2 expression was increased in the granular layer.
doi:10.1371/journal.pone.0013216.g001
Brn2 and Keratinocytes
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keratinocyte differentiation after intra-dermal injection
into rat skin
We performed in vivo intra-dermal injection of the purified Brn2
adenovirus into rat skin. One week after injection, the thickness of
the rat epidermis was increased to 6 to 8 cells, compared with 3–4
cells for uninjected skin or skin injected with either the PBS or
GFP adenovirus (Figure 5A). Consistent with the predominant
effects of Brn2 on the differentiation of cultured keratinocytes,
epidermal layers expressing keratin10 and loricrin were increased
by intra-dermal injection of Brn2 adenovirus (Figure 5B).
Expression of keratin 14 was not significantly different between
control- and Brn2-injected rat skin. There was no difference in the
number of positive cells in the basal layer stained with the
Figure 2. Keratinocyte differentiation by Brn2. (A) Expression of exogenous Brn2 in keratinocytes cultured in vitro. Cells were transduced with
adenovirus expressing GFP-tagged PITX2c (GFP-PITX2c) at 10 multiplicity of infection (MOI) for overnight. Cells were replenished with fresh medium
and incubated for 2 d. The expression of exogenous Brn2 was observed under the fluorescent microscopy. Adenovirus expressing GFP (Ad/GFP) was
used as a negative control. (B) Effect of PITX2c on the expression of differentiation markers. Keratinocytes were transduced with adenovirus
expressing GFP-Brn2 at the 10 MOI for overnight. Cells were replenished with fresh medium and incubated for the indicated time points. The mRNA
level was verified by RT-PCR. Involucrin, loricrin and filaggrin are the markers for keratinocyte differentiation. (C) Western blot analysis. Cellular
extracts were prepared after adenoviral transduction, and the protein level for differentiation markers was verified. In Western blot with anti-GFP
antibody, upper bands indicate the GFP-fused Brn2 and lower bands indicate the GFP protein. (D) Effect of Brn2 on the involucrin promoter activity.
Keratinocytes were transduced with 10 MOIs of involucrin-luc together with GFP-Brn2 expressing adenoviruses. Cells were lysed and assayed for
luciferase activity. Data are represented as fold induction and SEM, measured from three independent experiments.
doi:10.1371/journal.pone.0013216.g002
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However, p21-expressing layers were significantly increased
(Figure 5C). These results are not consistent with the decreased
proliferation rate of keratinocytes transduced with Brn2 adenovi-
rus (Figure 4A). Inconsistent results between in vitro cell cultures
overexpressing Brn2 and in vivo data are thought due to other
unknown in vivo factors that counteract the effect of Brn2.
Brn2 intra-dermal injected rat skin is similar to lichen
planus
Although it was not all the case, the histopathology of Brn2
injected skin in some mice was similar to human lichen planus.
Lichen planus is a well-known immunologically mediated skin
reaction resulting in 1) hyperparakeratosis with thickening of the
granular and spinous cell layers, 2) degeneration of the basal cell
layer, and 3) infiltration of inflammatory cells into the subepithelial
layer of connective tissue (Figure 6A). We examined the expression
of Brn2 in the skin lesions of lichen planus and found that Brn2-
expressing epidermal layers were highly increased in lichen planus
compared to normal skin (Figure 6B). Lichen planus is a T-cell-
mediated chronic inflammatory disease of unknown etiology. The
lymphocytic infiltrates in lichen planus are composed almost
exclusively of T-cells, and the majority of T-cells are activated
CD3
+ and CD8
+ lymphocytes [18–21]. Consistent with this
notion, CD3 positive T cells were infiltrated in the skin of the Brn2
adenovirus injected rat (Figure 6B). Thus, we hypothesized that
Brn2-overexpressing keratinocytes may have impact on T cell
migration. To test this idea, we used a chemotaxis assay with
Jurkat T cells using a modified Boyden chamber analysis. Brn2-
transduced keratinocytes attracted Jurkat T cells at about 6 fold
greater than that of GFP-transduced keratinocytes (Figure 7).
Thus, our results provide the first evidence that Brn2 has a role in
Figure 3. Chromatin Immunoprecipitation (ChIP) assay. (A) The
putative binding sites for Brn2 were searched by in silico analytical
method. (B) Keratinocytes were transduced with 10 MOIs of recombi-
nant adenoviruses for overnight. Cells were replenished with fresh
medium and cultured for 2 d. After cross-linking, nuclear fractions were
isolated and immunoprecipitated with normal IgG or Brn2 antibody.
Bindings of Brn2 to the promoters of involucrin, loricrin and filaggrin
were verified by PCR. GAPDH was used as a negative control.
doi:10.1371/journal.pone.0013216.g003
Figure 4. Effect of Brn2 on the growth of keratinocytes. (A)
Keratinocytes were transduced with 10 MOI of adenovirus expressing
GFP-Brn2 for overnight, washed twice with PBS, and incubated with
fresh medium containing [
3H]thymidine. At the indicated time points,
cells were lysed and radioactivity was measured by scintillation counter.
Control is non-virus transduced group. (B) Keratinocytes were
transduced with adenovirus expressing GFP-Brn2 at the 10 MOI for
overnight. Cells were replenished with fresh medium and incubated for
2 d. The protein level for cell cycle modulators were verified by Western
blot.
doi:10.1371/journal.pone.0013216.g004
Brn2 and Keratinocytes
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migration and by mediation of keratinocyte differentiation.
Discussion
In this study, we demonstrated that Brn2 mRNA and protein
levels were increased in 14 days after calcium treatment of primary
keratinocytes, consistent with its exclusive expression in the
granular layer of the normal epidermis. Using a recombinant
adenovirus technique, we showed that Brn2 has a potential for
promoting the keratinocyte differentiation. Actually, Brn2 induced
the expression of differentiation markers such as involucrin,
loricrin and filaggrin. These effects were believed to be a
consequence of direct binding of Brn2 to the promoters of such
genes, evidenced by ChIP assay. The most frequent targets of the
POU domain proteins are the ‘‘octamer’’ motifs (ATGCAAAT),
which are involved in both ubiquitous and cell-type specific
regulation of various genes [11,22]. These proteins also have the
flexibility to bind heterogeneous sequences, such as the so-called
TAATGARAT motif [22]. The proximal promoter region of the
human profilaggrin gene contains two AT-rich motifs that are
homologous to the consensus recognition sequence TAAT-
GARAT of the POU domain transcription factors [23,24]. In
our study, the Brn2 binding motifs of the involucrin, loricrin and
filaggrin promoter regions are not the same as the Oct binding
motifs. However, they do have AT-rich motifs and nearly all
binding sites have the same ATTTT motifs. Therefore, Brn2
increases differentiation of keratinocytes through increased
transcriptional activity via specific DNA binding to the promoter
regions of differentiation-related genes.
Despite its potential for promoting the keratinocyte differenti-
ation, in our study, the epidermal thickness of Brn2-injected rat
skin significantly increased with the increased differentiation in the
spinous and granular layers. Brn2 markedly inhibited cell
proliferation when overexpressed in cultured keratinocytes,
however cell proliferation in the basal layer looked like unaffected
by Brn2-injecton in rat skin. The discrepancy between in vitro and
in vivo data regarding cell proliferation remains to be elucidated.
Interestingly, in keap1-null mice, epidermal thickness is increased
along with the increased differentiation marker expression [25].
These results suggest that epidermal thickness is determined by the
balance of keratinocyte proliferation and differentiation, and it is
likely that the impairment of the balance between proliferation
and differentiation could lead to the thickening of epidermis.
Figure 5. Ectopic expression of Brn2 in rat skin. (A) Female Sprague Dawley (SD) rats were intradermally injected with 50 ml of Brn2 expressing
adenovirus (10
9 particles). After 7 days, skin specimens were harvested and stained with hematoxylin and eosin. Epidermal thickness of Brn2-injected
rat was greater relative to GFP-injected rat. CTL, non-injected; PBS, phosphate-buffered saline-injected. (B) Immunohistochemical staining of
keratinocyte differentiation markers. Paraffin-embedded tissue sections were stained with anti-GFP, anti-Brn2, anti-keratin 10 (K10), and anti-loricrin
antibodies. Expression of the early differentiation marker K10 and the late differentiation marker loricrin show that Brn2 can induces keratinocyte
differentiation. (C) Immunohistochemical staining of proliferation-related genes. Sections were stained with anti-p21, anti-p63, anti-keratin 14 (K14),
and anti-PCNA antibodies. The expression of p21 is increased in the Brn2-injected epidermis, there is no clear visible increase in K14 staining in the
basal layer of the epidermis as in normal epidermis and there is not a large difference in the expression of p63 or PCNA between the control and the
Brn2-injected epidermis.
doi:10.1371/journal.pone.0013216.g005
Brn2 and Keratinocytes
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all cells in the dermis including fibroblasts and possibly immune
cells and endothelial cells, there can be paracrine effects by which
the changes in the epidermis are happened. Actually, in our
preliminary study, overexpression of Brn2 in fibroblasts resulted in
increased expressions of IL-6 and IL-8 (Figure S1 and S2).
Furthermore, the conditioned medium collected from Brn2-
overexpressed fibroblasts induced the growth of keratinocytes as
compared with the control conditioned medium (Figure S3). Thus,
it is likely that epidermal thickening in Brn2-injected rat skin may
be partly linked to the paracrine effects of neighboring cells.
The histopathology of Brn2-injected rat skin was similar to
human lichen planus, showing hyperparakeratosis with thickening
of the granular cell layer, degeneration of the basal cell layer, and
infiltration of inflammatory cells into the subepithelial layer of
connective tissue. We demonstrated the Brn2 is highly expressed
in almost all epidermal cell nuclei in lichen planus using
immunohistochemistry with the anti-Brn2 antibody. High levels
of loricrin have been identified in the hypergranulotic and
hyperorthokeratotic epidermis of lichen planus in a study
exploring molecular alterations in keratinocyte differentiation in
lichen planus [26]. Involucrin has also been identified as a
diagnostic marker in oral lichenoid lesions based on observations
of involucrin reactivity in the skin and in oral lichen planus
[27,28]. There are also reports of high p53 and p21 expression
levels in oral lichen planus [29,30]. We found that overexpression
of Brn2 in keratinocytes changed the expressions of involucrin,
loricrin, p53 and p21, supporting the notion that Brn2 is closely
linked to the pathogenesis of lichen planus.
Lichen planus is a pruritic, papular eruption characterized by a
violaceous color, polygonal shape, and, sometimes, a fine scale. It
is most commonly found on the flexor surfaces of the upper
extremities, on the genitalia, and on mucous membranes. Lichen
planus skin lesions are thought to be an immunologically mediated
reaction involving T-cells because lichen planus histology is
characterized by a dense, subepithelial lympho-histiocytic infiltrate
with an increased number of intra-epithelial lymphocytes [31]. As
a consequence, degeneration of basal keratinocytes occurs forming
colloid (Civatte, hyaline, cytoid) bodies that appear as homogenous
eosinophilic globules [32–37]. Brn2 adenoviral injection of rat skin
led to detection of CD3 positive lymphocytes in the epidermis, but
not in GFP injected or normal control tissues. However, the
density of inflammatory cells in Brn2 injected skin was not as high
as in lichen planus, which is characterized by a band-like pattern
of inflammatory cell infiltration in subepidermal areas, denying the
role of Brn2 in the cause of lichen planus. Our observations of rat
skin were made after a one time injection with the Brn2
adenovirus. It is possible that Brn2 could attract more inflamma-
tory infiltrates, like in lichen planus, in a model in which Brn2 is
continuously produced. It is also possible that inflammation is
triggered by other mechanisms that induce Brn2 expression in
keratinocytes. Such mechanisms may exaggerate inflammation
while inducing terminal differentiation via positive feed back
cycles.
The lymphocytic infiltrates of lichen planus are composed
almost exclusively of T-cells with a high expression level of CD3
+
on the cell surface [38]. While the majority of T-cells within the
epithelium and adjacent to damaged basal keratinocytes is
activated CD8
+ lymphocytes with cytotoxic effects, most lympho-
cytes in the lamina propria are CD4
+ helper T-cells lacking
cytotoxic effects [18,20,39]. We also detected CD3 positive
lymphocytes in Brn2 adenovirus injected rat skin, but not in
GFP injected control tissues. Most inflammatory cells were
observed in the upper dermis with a few approaching the
epidermis. Some basal keratinocytes exhibited vacuolar changes,
which probably indicates the beginning of lichen planus.
Altogether, these results suggest that Brn2 may have a role for
pathogenesis of lichen planus. The precise relationship between
Brn2 and lichen planus, however, remains to be elucidated.
In conclusion, we provide evidence that Brn2 has a role in
mediating keratinocyte differentiation, and is possibly linked to
pathogenesis of lichen planus. Further research in this area should
Figure 6. The histopathology of Brn2-injected epidermis is
similar to human lichen planus. (A) In hematoxylin and eosin
staining of Brn2-injected epidermis, hyperkeratosis with thickening of
the granular cell layer, degeneration of the basal cell layer and
infiltration of inflammatory cells into the subepithelial layer of
connective are observed. (B) Immnunohistochemical analysis. T
lymphocyte marker CD3 is increased in Brn2-injected rat skin and
human lichen planus epidermis. Brn2 expression is increased in the
nucleus of lichen planus epidermis.
doi:10.1371/journal.pone.0013216.g006
Figure 7. Brn2 induced chemotaxis of T lymphocyte migration.
Jurkat cells were placed in upper well of Boyden’s chamber. In lower
well, keratinocytes were transduced with adenoviruses expressing GFP-
Brn2 or GFP for overnight, replenished with fresh medium and
incubated for 2 d. After assembly of upper and lower chambers, cells
were further incubated contained keratinocytes transduced with the
Brn2 and GFP adenoviruses for 48 h. After incubation for 24 h, the
number of Jurkat cells that migrated across the filter was counted.
doi:10.1371/journal.pone.0013216.g007
Brn2 and Keratinocytes
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absence of Brn2 expression in the epidermis.
Materials and Methods
Ethics Statement
All human skin samples were obtained under the written
informed consent of donors, in accordance with the ethical
committee approval process of the Institutional Review Board of
Chungnam National University School of Medicine (permit
number: 07-07, Development of skin specific microarray for gene
analysis of Korean atopic patients). All animal tests were approved
by the Institutional Review Board of Chungnam National
University School of Medicine (permit number, CNUCOM-
2007-14, Development of animal model for atopic dermatitis).
Cell culture
Primary epidermal keratinocytes were cultured according to the
method previously reported [40]. Keratinocytes were maintained
in keratinocyte-serum free medium (K-SFM) supplemented with
epidermal growth factor (EGF) and bovine pituitary extract (Gibco
BRL, Rockville, MD). Jurkat T lymphoma cells were maintained
in RPMI 1640 medium supplemented with 10% fetal bovine
serum (FBS) (Gibco BRL).
Immunohistochemical staining
Skin samples were fixed in 10% formalin for 24 h and
embedded in paraffin. Sections of skin specimens were dewaxed,
rehydrated, then washed three times with phosphate-buffered
saline (PBS). After treatment with proteinase K (1 mg/ml) for
5 min at 37uC, sections were treated with H2O2 for 10 min at
room temperature, placed in a blocking-solution (Dako, Carpin-
teria, CA) for 20 min, followed by reaction with the appropriate
primary antibodies. Sections were incubated sequentially with
peroxidase-conjugated secondary antibodies (Upstate, Lake Placid,
NY) and visualized using a Chemmate Envision Detection Kit
(Dako). Following antibodies were used in this study: Brn2, PCNA,
GFP, p63, p21, loricrin, PCNA and CD3
+ (SantaCruz Biotech-
nologies, Santa Cruz, CA); keratin 10, keratin 14 (Babco,
Richmond, CA).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNAs were isolated from keratinocytes using Easy-blue
RNA extraction kit (Intron, Daejeon, Korea). Two mg of total
RNAs were reverse transcribed with moloney-murine leukaemia
virus (M-MLV) reverse transcriptase (ELPIS Biotech, Daejeon,
Korea). Aliquots of RT mixture were subjected to PCR cycles with
appropriate primer sets. The sequences for primers were as
follows: Brn2, 59- GGAGTAGGGACACTCCACCA and 59-
CAGGAAGCTGCATTTTGTG; involucrin, 59-CAAAGAACC-
TGGAGCAGGAG and 59-CAGGGCTGGTTGAATGTCTT;
loricrin, 59-GTGGGAGCGTCAAGTACTCC and 59-AGAG-
TAGCCGCAGACAGAGC; filaggrin, 59-GGCACTCATCATG-
CAGAGAA and 59- ATGGTGTCCTGACCCTCTTG; cyclo-
philin, 59-CTCCTTTGAGCTGTTTGCAG and 59-CACCAC-
ATGCTTGCCATCCA.
Western blot analysis
Cells were lysed in Proprep solution (Intron). Total protein was
measured using a Bradford protein assay kit (Bio-Rad Laborato-
ries, Hercules, CA). Samples were run on SDS-polyacrylamide
gels, transferred onto nitrocellulose membranes and incubated
with appropriate antibodies. Blots were then incubated with
peroxidase-conjugated secondary antibodies, visualized by en-
hanced chemiluminescence (Intron). The following primary
antibodies were used in this study: involucrin, loricrin (Santa
Cruz Biotechnologies); Rb, p53 (Cell Signaling Technology,
Danvers, MA); actin (Sigma, St. Louis, MO).
Adenovirus
Aliquot of RT mixture was subjected to PCR cycles with primer
set for Brn2 (59-CGCTACGGATCCATGGCGACCGCAGCG-
TCTAA and 59-CGCTACGGATCC TCACTGGACGGGCG-
TCTGCA). The amplified full-length cDNA for PITX2c was
subcloned into pENT/CMV-GFP vector that has attL sites for
site-specific recombination with a Gateway destination vector. The
replication-incompetent adenoviruses were created using Vira-
power adenovirus expression system (Invitrogen) according to the
method previously described [41]. The adenovirus was purified
with cesium chloride according to the method previously reported
[42]. For creation of involucrin-luc reporter adenovirus, genomic
DNA isolated from keratinocytes was used as a template for PCR.
Primer sequences were as follows: involucrin promoter, 59-
CTCCATGTGTCATGGGATATG and 59-TCAACCTGAAA-
GACAGAAGAG. The resultant PCR fragments cover from
22,467 to +1,239 base pairs of involucrin transcription site
(http://www.ensembl.org/Multi/blastview).
ChIP assay
Cells were grown to 50% confluency and then transduced with
adenovirus expressing GFP-Brn2. After 2 day incubation, cells
were cross-linked using 1% formaldehyde (Sigma) at 37uC for
10 min, rinsed two times with cold PBS, and then harvested in
PBS containing protease inhibitors. ChIP assay was performed as
previously described [43].
Cell growth analysis
For determination of cell growth, [
3H]thymidine uptake assay
was performed. Keratinocytes cells were seeded in 60-mm culture
dish, transduced with adenovirus for overnight. Cells were
replenished with fresh medium containing 1 mCi of [
3H]thymidine
(Amersham, Buckinghamshire, UK). Following incubation for the
indicated time point, cells were washed twice with PBS and
incubated with 0.1 N NaOH at room temperature. Radioactivity
in cell lysates was measured by liquid scintillation counter.
Luciferase assay
Cells were grown at 50% confluency in a 12-well culture plate,
then co-transduced with reporter adenovirus and Brn2 expressing
adenovirus. After adenoviral transduction, cells were replenished
with fresh medium. Cells were further incubated for 48 h, and then
cellular extracts were prepared using cell lysis buffer. Luciferase
activities were determined using Luciferase assay system (Promega,
Madison, WI), according to the recommended protocol.
Intra-dermal injection of adenovirus in rat skin
Female Sprague Dawley (SD) rats, each weighing approximate-
ly 200 g, were used (Orient Bio, Gapyung, Korea). Fifty mlo f
recombinant virus solution (10
9 particles) prepared in PBS was
injected intradermally into the dorsal skin of rats using a
microsyringe with a 28-gauge hypodermic needle. The rats were
sacrificed 7 day after intradermal injection and the dorsal skins
were removed for histochemical analysis.
Chemotaxis assay
Chemotaxis assays were performed using a modified Boyden’s
chamber (Neuroprobe Inc., Gaithersburg, MD), as previously
Brn2 and Keratinocytes
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and 1.5610
5 of cells/ml was placed in the upper well of the
chamber. Lower well contained adenovirally transduced kerati-
nocytes. After incubation for 24 h at 37uC, non-migrated cells
were discarded, and cells that migrated across the filter were
counted.
Supporting Information
Figure S1 Dermal fibroblasts were transduced with recombinant
adenoviruses for 6 h. After replenishing with fresh growth medium
(DMEM supplemented with 10% FBS), cells were further cultured
for 2 d. Total RNAs were isolated and RT-PCR was performed.
Overexpression of Brn2 in fibroblasts resulted in increased
expressions of IL-6 and IL-8, while the expressions of IGF and
TGF-b were reduced.
Found at: doi:10.1371/journal.pone.0013216.s001 (0.65 MB TIF)
Figure S2 Dermal fibroblasts were transduced with the
indicated MOIs (multiplicity of infection) of recombinant adeno-
viruses for 6 h. After replenishing with fresh growth medium
(DMEM supplemented with 10% FBS), cells were further cultured
for 2 d. Culture medium were collected and the secreted IL-8 was
determined using ELISA kit (Human IL-8 CytoSetTM, Biosource,
Camarillo, CA). Overexpression of Brn2 led to increase of IL-8
secretion. Statistical significance was set at *P,0.05.
Found at: doi:10.1371/journal.pone.0013216.s002 (0.75 MB TIF)
Figure S3 Dermal fibroblasts were transduced with 10 MOIs of
recombinant adenoviruses for 6 h. Cells were replenished with
fresh growth medium (DMEM supplemented with 10% FBS), and
incubated for 1 d. Cells were then washed twice with PBS then
refed with KGM and incubated for a further 2 d. Culture medium
were collected and centrifuged. Supernatants were collected
(conditioned medium, CM), and added to the keratinocyte culture
at the 50% concentration. Keratinocytes were further incubated in
the presence of 1 mCi of [3H]thymidine (Amersham, Buck-
inghamshire, UK) for the indicated time points. Cells were washed
twice with PBS and incubated with 0.1 N NaOH at room
temperature. Radioactivity in cell lysates was measured by liquid
scintillation counter. Statistical significance was set at *P,0.05.
Found at: doi:10.1371/journal.pone.0013216.s003 (0.93 MB TIF)
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